financetom
Business
financetom
/
Business
/
Houston American Energy Files $300 Million Mixed Shelf Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Houston American Energy Files $300 Million Mixed Shelf Offering
Sep 16, 2025 2:52 PM

05:38 PM EDT, 09/16/2025 (MT Newswires) -- Houston American Energy ( HUSA ) late Tuesday filed a registration statement with the US Securities and Exchange Commission for a $300 million mixed shelf offering.

The company may offer and sell a combination of common stock, preferred stock, debt securities, warrants, rights, or units over time, it said.

It plans to use net proceeds from the offering in parts for general corporate purposes, working capital, product development, acquisitions and repayment of debt, among others.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Goldman CEO's leadership criticized by ethics group at annual meeting
Goldman CEO's leadership criticized by ethics group at annual meeting
Apr 24, 2024
SALT LAKE CITY, Utah (Reuters) - The conservative-leaning National Legal and Policy Center criticized Goldman Sachs ( GS ) CEO David Solomon's leadership at the bank's annual meeting on Wednesday. Mr. Solomon's poor decision making led to substantial losses in company's retail banking division, said Luke Perlot, associate director of the NLPC's corporate integrity project. (Reporting by Saeed Azhar in...
--McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3
--McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3
Apr 24, 2024
11:30 AM EDT, 04/24/2024 (MT Newswires) -- Price: 530.68, Change: -1.32, Percent Change: -0.25 ...
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Apr 24, 2024
11:33 AM EDT, 04/24/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Wednesday that the UK's Medicines and Healthcare Products Regulatory Agency has granted marketing authorization for Yorvipath as a parathyroid hormone, or PTH, replacement therapy to treat adults with chronic hypoparathyroidism. The UK regulator also granted orphan drug status to Yorvipath, or palopegteriparatide, providing 10 years of market...
Bank of America shareholders reject proposal to split CEO, chair roles
Bank of America shareholders reject proposal to split CEO, chair roles
Apr 24, 2024
NEW YORK, April 24 (Reuters) - Bank of America ( BAC ) shareholders rejected a proposal to divide the CEO and chairman roles held by Brian Moynihan on Wednesday at the company's virtual annual meeting. Proxy advisers had recommend investors vote for the bank to separate the positions in an effort to improve governance. The proposal was backed by 31%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved